GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (LSE:OBD) » Definitions » Enterprise Value

Oxford BioDynamics (LSE:OBD) Enterprise Value : £8.62 Mil (As of Dec. 14, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Oxford BioDynamics's Enterprise Value is £8.62 Mil. Oxford BioDynamics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was £-11.29 Mil. Therefore, Oxford BioDynamics's EV-to-EBIT ratio for today is -0.76.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Oxford BioDynamics's Enterprise Value is £8.62 Mil. Oxford BioDynamics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was £-9.82 Mil. Therefore, Oxford BioDynamics's EV-to-EBITDA ratio for today is -0.88.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Oxford BioDynamics's Enterprise Value is £8.62 Mil. Oxford BioDynamics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was £0.62 Mil. Therefore, Oxford BioDynamics's EV-to-Revenue ratio for today is 13.97.


Oxford BioDynamics Enterprise Value Historical Data

The historical data trend for Oxford BioDynamics's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics Enterprise Value Chart

Oxford BioDynamics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.59 83.46 43.22 16.68 76.04

Oxford BioDynamics Semi-Annual Data
Sep13 Sep14 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.96 16.68 23.04 76.04 23.83

Competitive Comparison of Oxford BioDynamics's Enterprise Value

For the Biotechnology subindustry, Oxford BioDynamics's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's Enterprise Value falls into.



Oxford BioDynamics Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Oxford BioDynamics's Enterprise Value for the fiscal year that ended in Sep. 2023 is calculated as

Oxford BioDynamics's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioDynamics  (LSE:OBD) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Oxford BioDynamics's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=8.617/-11.294
=-0.76

Oxford BioDynamics's current Enterprise Value is £8.62 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Oxford BioDynamics's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was £-11.29 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Oxford BioDynamics's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=8.617/-9.819
=-0.88

Oxford BioDynamics's current Enterprise Value is £8.62 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Oxford BioDynamics's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was £-9.82 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Oxford BioDynamics's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=8.617/0.617
=13.97

Oxford BioDynamics's current Enterprise Value is £8.62 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Oxford BioDynamics's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was £0.62 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioDynamics Enterprise Value Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics Business Description

Traded in Other Exchanges
Address
Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics Headlines

No Headlines